Susan Hasty, Publisher
Table of Contents . . . January 20th, 2003
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Diabetes Week | Other Publications
Bioengineering - Insulin release system gets boost from preproinsulin gene
Type 2 Diabetes Therapy - Glyburide/metformin effective in type 2 diabetic patients with poor glycemic control
Diabetes Monitoring - Nocturnal hypoglycemia occurs commonly in children with type 1 diabetes
Diabetes Vaccine - Neurologic disorders not associated with MMR vaccination
Glycemic Control - Visceral fat accumulation promotes insulin resistance
Type 2 Diabetes Risk Factor - Eating nuts and peanut butter prevents type 2 diabetes
Complementary and Alternative Medicine - Metabolife linked to diabetes
Diabetes - ANDA filed for generic Glucotrol XL
Diabetes Pathogenesis - Coxsackieviruses actually protect against type 1 diabetes in mice
Diabetes Therapy - Supplemental new drug application filed for Starlix
Endocrinology - Diabetes partnership to develop stem cell technologies
Financing - Stock purchase agreement to raise $3M
Gestational Diabetes - Diabetes diagnosed prior to pregnancy associated with infant malformations
Gestational Diabetes - Study: Insulin aspart controls postmeal glucose better than regular insulin
Hepatocellular Carcinoma - Synergism of alcohol with viral hepatitis and diabetes mellitus pose HCC risk
Kidney Transplantation - HCV infection linked to development of post-transplantation diabetes mellitus
Legal Issues - Patent challenge of DDAVP tablets announced
Macular Degeneration - Pfizer enters global collaboration for potential treatment for blindness
Obesity - Collaboration to target development of antiobesity compounds
Obesity - New state data show obesity and diabetes still on the rise
Overweight Interventions - Insurance company joins with CDC to take on obesity research
Type 2 Diabetes - Open-label study of AC2993 yields promising results
Weight Loss - Significant weight loss increases all-cause mortality in older adults
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.